Jodofenpropit

Jodofenpropit
	3-(1H-imidazol-5-il)propil N'-[2-(4-jodofenil)etil]imidotiokarbamat
Drugi nazivi	1-[3-(3H-imidazol-4-il)propiltio]-N'-[2-(4-jodofenil)etil]formamidin
Identifikacija
CAS registarski broj	143407-29-8
PubChem	3035746
MeSH	Iodophenpropit
ChEMBL	CHEMBL498770
Jmol-3D slike	Slika 1
SMILES
	C1=CC(=CC=C1CCN=C(N)SCCCC2=CN=CN2)I
InChI
	InChI=1S/C15H19IN4S/c16-13-5-3-12(4-6-13)7-8-19-15(17)21-9-1-2-14-10-18-11-20-14/h3-6,10-11H,1-2,7-9H2,(H2,17,19)(H,18,20) ; Kod: UBHYDQAARZKHEZ-UHFFFAOYSA-N
Svojstva
Molekulska formula	C15H19IN4S
Molarna masa	414,30763
	(šta je ovo?) (verifikuj) ; Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala
	Infobox references

Jodofenpropit je histaminski antagonist koji se selektivno vezuje za histaminski H₃ receptor. Njegov ¹²⁵I radioobeležen oblik se koristi za mapiranje distribucije H₃ receptora u telu.^[4]^[5]

Reference[uredi - уреди | uredi kôd]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Jansen, FP; Wu, TS; Voss, HP; Steinbusch, HW; Vollinga, RC; Rademaker, B; Bast, A; Timmerman, H (1994). „Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, 125I-iodophenpropit, to rat brain”. British Journal of Pharmacology 113 (2): 355–62. PMC 1510107. PMID 7834183. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1510107/.
↑ Jansen, FP; Mochizuki, T; Maeyama, K; Leurs, R; Timmerman, H (2000). „Characterization of histamine H3 receptors in mouse brain using the H3 antagonist 125Iiodophenpropit”. Naunyn-Schmiedeberg's archives of pharmacology 362 (1): 60–7. DOI:10.1007/s002100000227. PMID 10935534.

Spoljašnje veze[uredi - уреди | uredi kôd]

Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[4] Jansen, FP; Wu, TS; Voss, HP; Steinbusch, HW; Vollinga, RC; Rademaker, B; Bast, A; Timmerman, H (1994). „Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, 125I-iodophenpropit, to rat brain”. British Journal of Pharmacology 113 (2): 355–62. PMC 1510107. PMID 7834183. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1510107/.

[5] Jansen, FP; Mochizuki, T; Maeyama, K; Leurs, R; Timmerman, H (2000). „Characterization of histamine H3 receptors in mouse brain using the H3 antagonist 125Iiodophenpropit”. Naunyn-Schmiedeberg's archives of pharmacology 362 (1): 60–7. DOI:10.1007/s002100000227. PMID 10935534.

[1]

[2]

[3]

[4]

[5]

Jodofenpropit

Reference[uredi - уреди | uredi kôd]

Spoljašnje veze[uredi - уреди | uredi kôd]

Navigacijski meni

Traži-Тражи